Premier Edition of Clinical Management of Cardiovascular Risk in Diabetes and Obesity by Drs. Yehuda Handelsman and Robert S. Rosenson
Professional Communications is pleased to announce the publication of the premier edition of Clinical Management of Cardiovascular Risk in Diabetes and Obesity by Drs. Yehuda Handelsman and Robert S. Rosenson.
Adults with diabetes are two to four times more likely to have coronary heart disease or a stroke than adults without diabetes. Approximately two thirds of all people with diabetes die from some form of heart disease or stroke. Obesity is one of the main factor driving the incidence of type 2 diabetes. The goal of this book is to address the challenges involved in the management of risk factors for the prevention of cardiovascular disease (CVD) with diabetes and/or obesity who have significantly higher risk for CVD morbidity and mortality. The authors provide detailed guidance for a comprehensive approach to risk reduction in these patients.
Clinical Management of Cardiovascular Risk in Diabetes and Obesity features the 2013 ACCE Comprehensive Diabetes Management Algorithms that include CVD Risk Factor Modifications and Complications-Centric Model for Care of the Overweight/Obese Patient algorithms. A chapter listing for Clinical Management of Cardiovascular Risk in Diabetes and Obesity is as follows:
Chapter 1: Diabetes, Obesity, and Cardiovascular Disease
Chapter 2: Components of CVD Risk: Mechanisms and Interactions
Chapter 3: Patient-Centered Assessment and Management Recommendations
Chapter 4: Weight Loss as a Primary Intervention
Chapter 5: Management of Hypertension
Chapter 6: Management of Dyslipidemia
Chapter 7: Management of Hyperglycemia
Chapter 8: Additional Concerns in Special Populations
Chapter 9: Conclusions/Summary and Recommendations
Chapter 10: Abbreviations/Acronyms
Chapter 11: Index
Yehuda Handelsman, MD was one of the key authors in the 2011 AACE Guidelines for diabetes management and the 2013 AACE diabetes management algorithms and Immediate Past President of the American College of Endocrinology (ACE) and past president of the American College of Clinical Endocrinology (AACE). Robert S. Rosenson, MD is Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine at Mount Sinai.
2016 • 368 pages • 4 color • ISBN: 978-1-932610-96-3 • $34.95